跳至主要内容
临床试验/JPRN-UMIN000029032
JPRN-UMIN000029032已完成未知

Study on the symptom control of gastric acid suppressive drugs in reflux esophagitis patients - Study on the recurrent symptom after suspension of therapy with gastric acid suppressive drugs in reflux esophagitis patients

Marru-clinic Yokosuka Department of Gastroenterology0 个研究点目标入组 30 人开始时间: 2017年9月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

In the results, between the PCAB (5 cases/30 cases, 33%) and PPI (6 cases/30 cases, 40.0%) groups in the proportion of patients with a positive symptom score of at least 1 point at 2 weeks after discontinuation, there was no statistically significant difference (chi-square test, p = 0.705) . Negative symptom scores were not also statistically significantly different between the PCAB (7 cases, 46%) and PPI (4 cases, 26.7%) groups (chi-square test, p = 0.256).

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with warning signs such as vomiting, gastrointestinal bleeding (including findings of hematemesis, melena, and anemia), and sudden weight loss 2. Patients confirmed or suspected malignant lesion 3. Patients with a history of gastrointestinal resection or vagotomy 4. Patients in Irritable Bowel Syndrome 5. Patients whose participation in this study would be contraindicated due to complications such as serious hepatic disease, renal disease, or cardiac disease 6. Women who are pregnant or who may possibly be pregnant, and lactating mothers 7. Other patients whom the investigator considers unsuitable for admission to the study

研究者

发起方
Marru-clinic Yokosuka Department of Gastroenterology

相似试验